Xeris Pharmaceuticals Inc reported $24.46M in Gross Profit on Sales for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Acelrx Pharmaceuticals ACRX:US USD -62000 244K
Eli Lilly And LLY:US USD 5.75B 391.2M
Endo International Ordinary Shares ENDP:US USD 364.83M 28.49M
Horizon Pharma HZNP:US USD 691.23M 45.03M
JAZZ PHA JAZZ:US USD 806.99M 1.68M
Nektar Therapeutics NKTR:US USD 18.65M 2.18M
Pacira Pharmaceuticals PCRX:US USD 116.79M 2M
Perrigo Ordinary Shares PRGO:US USD 362.9M 9.2M
Teva Pharmaceutical Industries TEVA:US USD 1.71B 118M